Tiger Global Management Co-Invests $133M In China’s B2B Pharma Trading Firm Yaoshibang
December 17, 2018 — 12:22 CST
This Data Is Locked!
This area is available only to Subscribers.
Yaoshibang, a Guangzhou-based business-to-business (B2B) pharmaceutical trading platform, announced that it has completed a US$133 million new round of financing from Tiger Global Management, DCM... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals